Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
1000 participants
OBSERVATIONAL
2023-04-01
2028-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of his prospective study is to collect a large bulk of postoperative patients' outcome data and to produce up-to-date descriptive statistics of patients undergoing surgery for lung cancer. These results will be pivotal to compare the clinical results of all the relevant specialities involved in the care of lung cancer such as medical oncologists and radiation oncologists.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lung Cancer Multi-omics Digital Human Avatars for Integrating Precision Medicine Into Clinical Practice
NCT05802771
National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria
NCT02725892
Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies
NCT06254196
Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects
NCT06800586
Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer
NCT01799395
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* informed consent
Exclusion Criteria
* age \< 18
* inability to express consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
S. Andrea Hospital
OTHER
Azienda Policlinico Umberto I
OTHER
Azienda Ospedaliero, Universitaria Pisana
OTHER
Università degli Studi dell'Aquila
OTHER
University of Milan
OTHER
Azienda Ospedaliera di Perugia
OTHER
Monaldi Hospital
OTHER
Azienda Ospedaliera di Bolzano
OTHER
AUSL Romagna Rimini
OTHER
European Institute of Oncology
OTHER
Università degli Studi di Ferrara
OTHER
Azienda Socio Sanitaria Territoriale di Mantova
OTHER
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roberto Crisci, MD
Role: PRINCIPAL_INVESTIGATOR
University of Aquila
Luca Bertolaccini, MD
Role: PRINCIPAL_INVESTIGATOR
European Institute of Oncology
Alessandro Bertani, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS ISMETT -UPMC ITALY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of L'Aquila
L’Aquila, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bertolaccini L, Ciani O, Lucchi M, Zaraca F, Bertani A, Crisci R, Spaggiari L; LUCENT Study Group. Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT). JMIR Res Protoc. 2024 Oct 8;13:e57183. doi: 10.2196/57183.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRRB/04/23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.